Skip to main content

Fertility Disorders

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
1 program
KinderN/A1 trial
Active Trials
NCT05634850Unknown25Est. Jun 2023
IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
DUOSTIMPHASE_31 trial
Active Trials
NCT03803228Completed88Est. Nov 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IBSA Institut BiochimiqueDUOSTIM
Innovation PharmaceuticalsKinder

Clinical Trials (2)

Total enrollment: 113 patients across 2 trials

Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders

Start: Sep 2018Est. completion: Nov 202188 patients
Phase 3Completed

Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.

Start: Sep 2022Est. completion: Jun 202325 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.